Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong
· Delayed Price · Currency is HKD 1.110
+0.040 (3.74%)
At close: Mar 10, 2026
HKG:1652 Revenue
Fusen Pharmaceutical Company had revenue of 111.29M CNY in the half year ending June 30, 2025, a decrease of -66.92%. This brings the company's revenue in the last twelve months to 240.99M, down -43.36% year-over-year. In the year 2024, Fusen Pharmaceutical Company had annual revenue of 326.03M, down -42.36%.
Revenue (ttm)
240.99M CNY
Revenue Growth
-43.36%
P/S Ratio
3.00
Revenue / Employee
230.62K CNY
Employees
1,045
Market Cap
791.05M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 326.03M | -239.58M | -42.36% |
| Dec 31, 2023 | 565.61M | 73.85M | 15.02% |
| Dec 31, 2022 | 491.76M | 106.09M | 27.51% |
| Dec 31, 2021 | 385.66M | -101.19M | -20.78% |
| Dec 31, 2020 | 486.85M | 79.47M | 19.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lee's Pharmaceutical Holdings | 1.44B |
| Pak Fah Yeow International | 199.55M |
| Zhongzhi Pharmaceutical Holdings | 2.20B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| China NT Pharma Group Company | 20.45M |
| Chia Tai Enterprises International | 4.17B |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |